Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ketamine Challenge Study With JNJ-40411813

This study has been completed.
Information provided by (Responsible Party):
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Identifier:
First received: April 8, 2010
Last updated: April 7, 2014
Last verified: April 2014